The corporate governance practices and the disclosures are need based, complied with the statutory and the regulatory requirements of the Companies Act, 2013, together with all the relevant Clauses of the Listing Agreement and all the others applicable laws. The Company’s Corporate Governance policies and the practices are also in accordance with the amended Clause 49 of the listing agreement. A report on the Corporate Governance along with the Auditors Certificate forming part of the Director’s report, being annexed herewith.
Code of Conduct for Independent Directors Schedule IV

COMPANYS PHILOSOPHY ON CODE OF GOVERNANCE

Our corporate governance policies recognise the accountability of the Board and the importance of its decisions to all our constituents, including customers, investors and the regulatory authorities and to demonstrate that the shareholders are the cause of and ultimate beneficiaries of our economic activities. The functions of the Board and the Executive Management are well defined and are distinct from one another. We have taken a series of steps including the setting up of sub-committees of the Board to oversee the functions of Executive Management. These sub-committees of the Board, which mainly consists of Non-Executive Directors, meet regularly to discharge their objectives.

ANNEXURE I

To,
The Compliance Officer
Medicaps Ltd.
Mhow-Neemuch Road,
Pithampur, Districrt Dhar (M.P.)
Sub : Confirmation of Compliance of the Code of Conduct of Medicaps Limited.
I ______________________________ (name), ___________________ (designation) of the Company, do hereby confirm that I have fully complied with the provisions of the Code of Conduct of the Medicaps Limited. for the Accounting year ending on 31st March, 200__.
Signature _________________
Name ____________________
Date _____________________
Place ____________________

• ARCHIVAL POLICY
• CODE OF CONDUCT FOR BOARD OF DIRECTORS AND KMP’S
• WHISTLE BLOWER/VIGIL MECHANISM POLICY
• INSIDER CODE OF CONDUCT ( W.E.F. 14.05.2015 )
• INSIDER CODE OF FAIR DISCLOSURE ( W.E.F. 14.05.2015 )
• NOMINATION AND REMUNERATION POLICY
• POLICY FOR DETERMINING MATERIAL SUBSIDIARY
• POLICY FOR DETERMINATION OF MATERIALITY
• POLICY FOR PRESERVATION OF DOCUMENTS
• CONTACT DETAILS OF CS AND CFO
• RISK MANAGEMENT POLICY
• Familiarization Policy Updation – 2022-23
• Policy for Appointment of Directors and criteria for determining the qualifications, positive attitude and Independence of a Directors.
• Amended Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information (UPSI) as per Regulation 8(2) of the SEBI(Prohibition of Insider Trading) Regulations, 2015(w.e.f 01.04.2019)
• Code of Conduct (W.E.F. 01st April, 2019)
• POLICY FOR PROCEDURE OF INQUIRY IN CASE OF LEAK OF UNPUBLISHED PRICE SENSITIVE INFORMATION OR SUSPECTED LEAK OF UNPUBLISHED PRICE SENSTIVE INFORMATION (“UPSI”)
• Related Party Transaction Policy w.e.f 25.07.2018
• Submission of Code of Fair Disclosure under Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 dFD-28.05.2019.swue to change in the name of the Chief Investor Relations Officer
• Code of Conduct under Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time due to change in the name of the Compliance Officer
• Code of Conduct amended on 25th August, 2020
• POLICY ON SUCCESSION PLAN